RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients - Concepedia

Concepedia

Publication | Open Access

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

DOI Full Paper Access

57

Citations

50

References

2013

Year

Sam Cross-Knorr, Shaolei Lu, Kimberly Perez, Sara Guevara, Kate E. Brilliant, Claudio Pisano, Peter J. Quesenberry, Murray B. Resnick, Devasis Chatterjee

References

	Year	Citations

Page 1